Christopher Sutton

Christopher Sutton has a diverse work experience spanning over two decades. Christopher began their career as a Senior Research Scientist at Prometheus Laboratories, Inc., where they developed diagnostic assays and integrated external technologies into operations. Christopher then joined Santarus, Inc. as a Project Manager, overseeing a combination GI therapy project and managing the Scientific Advisory Board.

After working at Labcorp as the Manager of Post-PCR Operations, Sutton joined the David Geffen School of Medicine at UCLA as a Visiting Assistant Researcher. During this time, they conducted post-doctoral research in Inflammatory Bowel Disease, obtained approvals for animal and human experimentation, and coordinated intellectual property creation and transfer.

Sutton later played various roles at Crescendo Bioscience, including Senior Director, Vice President of Operations, and Secretary of the Board of Directors. In these positions, they managed biomarker discovery and development programs, established a CLIA regulated laboratory for multiplex protein assays, and co-founded Riley Genomics Inc.

Christopher then served as the Chief Operating Officer at PolySkope Labs and Vice President of Business Development at Haus Bioceuticals, Inc. In these roles, they contributed to operational management and business development strategies.

In their most recent role as the Vice President of Quality at Spaus, Inc., Sutton focuses on maintaining high-quality standards within the company.

Additionally, Sutton has worked as a Reviewer for the NIH Immunology Review Committee, evaluating grants for SBIR and other NIH programs, and even served as the committee Chairman in 2019. Christopher also worked as a Project Management Consultant at Intergity Testing, where they provided expertise in project management.

Throughout their career, Sutton has demonstrated a strong background in scientific research, diagnostic assay development, laboratory management, and business development.

Christopher Sutton has a diverse education history. Between 1988 and 1994, they attended the David Geffen School of Medicine at UCLA, where they earned a Doctor of Philosophy (Ph.D.) in Biological Chemistry. Prior to that, from 1982 to 1984, they studied Molecular Biology at the University of Wisconsin-Milwaukee, earning a Bachelor of Science (BS) degree. From 1979 to 1981, they attended Washington University in St. Louis, focusing on Chemical Engineering, although no specific degree was mentioned. Additionally, Sutton pursued a Ph.D. in Molecular Biology at the University of California, Los Angeles, but the exact years of study are not provided.